Clari Vest Asset Management LLC Vaxcyte, Inc. Transaction History
Clari Vest Asset Management LLC
- $1 Billion
- Q3 2024
A detailed history of Clari Vest Asset Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 4,140 shares of PCVX stock, worth $355,791. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,140
Previous 4,140
-0.0%
Holding current value
$355,791
Previous $312,000
51.28%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
360Shares Held
124MCall Options Held
748KPut Options Held
418K-
Vanguard Group Inc Valley Forge, PA12MShares$1.03 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$939 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$854 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$747 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$421 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.1B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...